Endothelial apoptotic activity of angiocidin is dependent on its polyubiquitin binding activity

British Journal of Cancer

Volumn 93, Issue 6, 2005, Pages 662-669

  Dimitrov, S ^a   Sabherwal, Y ^a   Raymond, D D ^a   L'Heureux, D Z ^a   Lu, Q ^a,b   Tuszynski, G P ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Angiocidin; Polyubiquitin; Proteosome

Indexed keywords

ANGIOCIDIN; ANTIBODY; POLYUBIQUITIN; PROTEASOME; RECOMBINANT PROTEIN; UBIQUITIN ANTIBODY; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UBIQUITINATION; UMBILICAL VEIN;

ANTIGENS, SURFACE; APOPTOSIS; BINDING SITES; CARRIER PROTEINS; CELLS, CULTURED; CHROMATOGRAPHY, AFFINITY; ENDOTHELIUM, VASCULAR; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; POLYUBIQUITIN; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; RECOMBINANT PROTEINS; UMBILICAL VEINS;

EID: 27144472721     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602773     Document Type: Article

References (15)

1. Adams J (2001) Proteasome inhibition in cancer: development of PS-341. Semin Oncol 28: 613-619
2. Aida Y, Pabst MJ (1990) Removal of endotoxin from protein solutions by phase separation using Triton X-114. J Immunol Methods 132: 191-195
3. Chauhan D, Hideshima T, Mitsiades C, Richardson P, Anderson KC (2005) Proteasome inhibitor therapy in multiple myeloma. Mol Cancer Ther 4: 686-692
4. Ciehanover A, Hod Y, Hershko A (1978) A heat-stable polypeptide component of an ATP-dependent proteolytic system from reticulocytes. Biochem Biophys Res Commun 81: 1100-1105
5. Driscoll J, Goldberg AL (1990) The proteasome (multicatalytic protease) is a component of the 1500-kDa proteolytic complex which degrades ubiquitin-conjugated proteins. J Biol Chem 265: 4789-4792
6. Haroon ZA, Hettasch JM, Lai TS, Dewhirst MW, Greenberg CS (1999) Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis. FASEB J 13: 1787-1795
7. Hershko A, Ciechanover A (1998) The ubiquitin system. Annu Rev Biochem 67: 425-479
8. Jesenberger V, Jentsch S (2002) Deadly encounter: ubiquitin meets apoptosis. Nat Rev Mol Cell Biol 3: 112-121
9. Johansson E, Jennische E, Lange S, Lonnroth I (1997) Antisecretory factor suppresses intestinal inflammation and hypersecretion. Gut 41: 642-645
10. Nilsson LA, Lange S, Lonnroth I (1992) Induction of anti-secretory factor in mice by the nonintestinal parasite Schistosoma mansoni. J Parasitol 78: 1055-1058
11. Rechsteiner M, Hoffman L, Dubiel W (1993) The multicatalytic and 26 S proteases. J Biol Chem 268: 6065-6068
12. Schmidt MH, Furnari FB, Cavenee WK, Bogler O (2003) Epidermal growth factor receptor signaling intensity determines intracellular protein interactions, ubiquitination, and internalization. Proc Natl Acad Sci USA 100: 6505-6510
13. Tuszynski GP, Rothman VL, Papale M, Hamilton BK, Eyal J (1993) Identification and characterization of a tumor cell receptor for CSVTCG, a thrombospondin adhesive domain. J Cell Biol 120: 513-521
14. Young P, Deveraux Q, Beal RE, Pickart CM, Rechsteiner M (1998) Characterization of two polyubiquitin binding sites in the 26 S protease subunit 5a. J Biol Chem 273: 5461-5467
15. Zhou J, Rothman VL, Sargiannidou I, Dimitrov S, Qiu C, Smith E, Sheffield J, Sharma M, Tuszynski GP (2004) Cloning and characterization of angiocidin, a tumor cell binding protein for thrombospondin-1. J Cell Biochem 92: 125-146